Search

Your search keyword '"Hattori, Y"' showing total 3,582 results

Search Constraints

Start Over You searched for: Author "Hattori, Y" Remove constraint Author: "Hattori, Y"
3,582 results on '"Hattori, Y"'

Search Results

2. Impact ionization and transport properties of hexagonal boron nitride in constant-voltage measurement

4. Discovery of molecular and atomic clouds associated with the gamma-ray supernova remnant Kesteven 79

5. Fully dry PMMA transfer of graphene on h-BN using a heating/cooling system

6. Layer-by-Layer Dielectric Breakdown of Hexagonal Boron Nitride

7. The two molecular clouds in RCW 38; evidence for formation of the youngest super star cluster in the Milky Way triggered by cloud-cloud collision

8. Cloud-cloud collision as a trigger of the high-mass star formation; a molecular line study in RCW120

9. Large-scale mapping of the massive star-forming region RCW38 in the [CII] and PAH emission

12. Reconnection and acoustic emission of quantized vortices in superfluid by the numerical analysis of the Gross-Pitaevskii equation

13. Enhancement of fluorescence and photostability of luminescent radicals by quadruple addition of phenyl groups

16. Daily Variation of Masseter EMG WaveformsDuring Daytime Wakefulness

19. Long-Term Outcomes of Image-Guided Proton Therapy with Gold Fiducial Marker for Localized Prostate Cancer.

22. 977P Phase II study of brigatinib in patients with tyrosine kinase inhibitor (TKI)-naïve ROS1-rearranged advanced non-small cell lung cancer (NSCLC): Barossa cohort 1

25. First demonstration of the use of open-shell derivatives as organic luminophores for transparent luminescent solar concentrators

28. List of Contributors

38. Hippocampal Sparing Radiotherapy in adults with Primary Brain Tumors: A comparative planning and dosimetric study using IMPT, IMRT and 3DCRT

39. Newly developed EMF cell with zirconia solid electrolyte for measurement of low oxygen potentials in liquid Cu-Cr and Cu-Zr alloys

46. Oncogenes of Stomach Cancers

47. P45.04 Phase II Study of Brigatinib in ROS1 Positive Non-Small Cell Lung Cancer (NSCLC) Patients Previously Treated with Crizotinib: Barossa Cohort 2

48. 1443MO Differences in hematologists’ and palliative care physicians’ recommended indications and opinions on transfusion therapy for patients with hematological malignancy post-anticancer therapy

Catalog

Books, media, physical & digital resources